Blanket Purchase Agreement FA520925A0016
- Not listed
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Ortho Clinical Diagnostics K.K., a Japanese subsidiary of Ortho Clinical Diagnostics, to provide chemistry and immunoassay testing system reagents and consumable supplies. The $2,875,000 BPA has an ultimate completion date of June 30, 2029 and supports medical facilities operated by the U.S. military in Japan, including naval hospitals and air force bases. The task orders issued under this BPA have ceiling...
- The Department of the Air Force Pacific Air Forces awarded Ortho Clinical Diagnostics K.K. a single-award blanket purchase agreement with a potential value of $250,000 to provide reagents for clinical laboratory chemistry and immunoassay testing systems. The BPA has a period of performance through June 30, 2022. The original solicitation sought a service provider to supply a chemistry analyzer, related reagents, equipment, and maintenance services to the 374th Medical Group at Yokota Air Base in...
- The Department of the Air Force Pacific Air Forces awarded Ortho Clinical Diagnostics K.K. a blanket purchase agreement with a potential value of $2,526,958.35 to provide a clinical laboratory chemistry and immunoassay testing system. The single award BPA does not include any set aside designations and has an ordering period through April 2026. In October 2021, the 35th Medical Group issued a decentralized call against the BPA valued at $574,412.31. The firm fixed price call is for laboratory...
- This Blanket Purchase Agreement (BPA) with the Defense Health Agency (DHA) awards a single prime contract to Ortho-Clinical Diagnostics GMBH, a for-profit organization specializing in diagnostic systems and medical supplies. The $1,200,000 IDV covers the provision of consumables compatible with the government-owned Ortho Vision Analyzer through September 30, 2029. The BPA demonstrates Ortho-Clinical Diagnostics GMBH's established track record of supplying critical diagnostic products and...
- The Defense Health Agency (DHA) awarded a single-award Indefinite Delivery Contract to Ortho-Clinical Diagnostics, Inc., valued at $771,818.90, with an award date of October 1, 2024, and ultimate completion date of September 30, 2025. This contract procures Ortho Clinical Diagnostics reagents and consumables, as well as Ortho Vision reagents, to support medical laboratory operations at Brian Allgood Army Community Hospital (BDAACH) in South Korea. The underlying solicitation, posted as a Sources...
- Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch has been awarded a single-award Indefinite Delivery Contract valued at $1.25M by the Defense Health Agency, with a performance period from February 1, 2025, through September 30, 2026. The primary objective of this contract is to supply VITROS XT7600 reagents and consumables to support medical operations at U.S. military healthcare facilities in South Korea, specifically the 51st Medical Group Medical Treatment Facility at Osan Air Base...
- Ortho-Clinical Diagnostics Inc. was awarded a single award blanket purchase agreement by the Defense Health Agency to support a new blood bank. The potential value of the agreement is $673,272 over a four year base period ending in September 2027. Under the blanket purchase agreement, Ortho-Clinical Diagnostics Inc. will provide products and services to the Defense Health Agency to support operations of a new blood bank. As a manufacturer of medical equipment and diagnostics, Ortho-Clinical...
- This Blanket Purchase Agreement (BPA) was awarded by the Uniformed Services University of the Health Sciences, a defense agency, to the prime contractor Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The $1,000,000 single-award BPA, awarded on July 1, 2016 with an ultimate completion date of October 2, 2024, is for equipment maintenance services. Ortho-Clinical Diagnostics Inc. has a history of securing federal contract...
- The Department of the Army Medical Command awarded a single-award blanket purchase agreement to Ortho-Clinical Diagnostics GMBH on August 27, 2020, with a potential value of $2,000,000. The BPA is for medical supplies compatible with Ortho Vitros analyzers to support the agency's healthcare facilities. No set-aside provisions were used. A subsequent firm fixed price call was placed against the BPA on September 8, 2023, valued at $10,728.66. Ortho-Clinical Diagnostics GMBH will provide its...
- Ortho-Clinical Diagnostics, Inc. was awarded a single-award Blanket Purchase Agreement by the Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base with a ceiling value of $1,638,402.55 and ultimate completion date of October 28, 2026. The contract, awarded on October 29, 2021 without set-aside designation, procures an automated chemistry testing platform for the 88th Medical Group Laboratory in accordance with the statement of work. The vendor, headquartered in...
Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostic solutions provider Ortho Clinical Diagnostics, has been awarded a single-award Blanket Purchase Agreement (BPA) by the Defense Health Agency with a ceiling value of $250,000 and a performance period extending through September 30, 2030. This BPA, effective October 1, 2025, procures laboratory medical supplies for the Medical Department Activity (MEDDAC) in Japan, with no socioeconomic set-aside provisions applied. The contractor specializes in supplying VITROS chemistry and immunoassay testing systems, including reagents and consumable supplies, which are critical diagnostic equipment and materials used in clinical laboratory operations at U.S. military medical facilities throughout Japan. The contracted supplies support laboratory diagnostic testing operations across multiple U.S. military medical installations in the Indo-Pacific region, including naval hospitals in Yokosuka, Atsugi, Sasebo, and Iwakuni, as well as military medical research centers and air force bases. These deliverables serve active duty personnel, dependents, and retirees requiring clinical laboratory diagnostics and medical testing services. Ortho Clinical Diagnostics K.K. holds an established track record of providing firm fixed-price delivery orders for similar laboratory diagnostic supplies to the Department of Navy and Defense Health Agency, positioning this BPA as a continuation of sustained procurement support for military medical operations in Japan. The agreement enables streamlined acquisition of essential laboratory consumables and testing systems necessary for ongoing clinical diagnostics and medical research operations within the U.S. military healthcare system in the region.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/25/25 |